Diaz LS, Navalon CI, Espin RG, Prado IN, et al. Impact of proactive of infliximab monitoring using the Bayesian approach in the maintenance phase in patients with inflammatory bowel disease. Gastroenterol Hepatol 2023;46:504-511.
PMID: 36400260